If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £74.17m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re Intended Offers for Subscription

18 Jun 2024 11:53

RNS Number : 9023S
Maven Income & Growth VCT PLC
18 June 2024
Β 

Not for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan, the Republic of South Africa or any jurisdiction for which the same could be unlawful. The information contained herein does not constitute an offer of securities for sale in any jurisdiction, including in the United States, Canada, Australia, Japan or the Republic of South Africa.

Β 

Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

(the "Companies")

Β 

Statement re Intended Offers for Subscription

Β 

The Directors of the Companies are pleased to announce their intention to raise up to Β£40 million, in aggregate, including over-allotment facilities of, in aggregate, up to Β£20 million, by way of offers for subscription of new ordinary shares (the "Offers"). Each Company will raise up to Β£10 million, including an over-allotment facility of up to Β£5 million. Shares will be issued in the 2024/25 and 2025/26 tax years.

Having considered the current cash reserves of the Companies and the amounts intended to be raised under the Offers, the Boards are confident that, given the strength of the current pipeline of investment opportunities, the Companies' Manager, Maven Capital Partners UK LLP, will continue to be able to identify and complete VCT qualifying transactions in line with each Company's investment strategy.

A prospectus, with full details of the Offers, is intended for publication in the Autumn of 2024. A further announcement will be made when the prospectus is available.

Applicants will be able to invest in any or all of the Offers, in accordance with the terms to be set out in the prospectus and subject to the relevant Offer(s) selected still remaining open.

It is anticipated that the Offers will remain open until no later than 5 April 2025 in respect of the 2024/25 tax year and until 25 April 2025 in respect of the 2025/26 tax year, unless an Offer is fully subscribed at an earlier date and subject to each Board's right to close or extend the relevant Offer at any time.

Β 

On behalf of the Boards

Maven Capital Partners UK LLP

Secretary

18 June 2024

Β 

Notes

Β 

1. The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

2. This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRBVLFFZQLEBBF
Date   Source Headline
15th Jun 20155:28 pmRNSDirector/PDMR Shareholding
12th Jun 201510:06 amRNSIssue of Equity
5th Jun 20153:19 pmRNSNet Asset Value(s)
12th May 20154:47 pmRNSDirector/PDMR Shareholding
12th May 20154:45 pmRNSTransaction in Own Shares
11th May 20154:49 pmRNSTransaction in Own Shares
28th Apr 20154:41 pmRNSNet Asset Value(s)
21st Apr 20153:08 pmRNSResult of AGM
13th Apr 20153:14 pmRNSIssue of Equity
6th Mar 20152:40 pmRNSAnnual Financial Report
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201511:50 amRNSDirector/PDMR Shareholding
26th Feb 201511:49 amRNSDirector/PDMR Shareholding
26th Feb 201511:46 amRNSDirector/PDMR Shareholding
20th Feb 20152:53 pmRNSIssue of Equity
17th Feb 20159:21 amRNSStatement re Offers and Related Party Transactions
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
28th Jan 20152:19 pmRNSNet Asset Value(s)
20th Jan 20159:48 amRNSStatement re Offers for Subscription
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
6th Jan 20154:47 pmRNSForm 8.3 - [Armour Group PLC] Replacement
6th Jan 201512:13 pmRNSForm 8 (DD) - Armour Group PLC
13th Nov 20142:31 pmRNSTransaction in Own Shares
6th Nov 20143:55 pmRNSTransaction in Own Shares
5th Nov 20144:20 pmRNSTransaction in Own Shares
4th Nov 201411:46 amRNSTransaction in Own Shares
3rd Nov 20143:59 pmRNSTransaction in Own Shares
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
9th Oct 201412:30 pmRNSInterim Management Statement
3rd Oct 20144:27 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
21st Aug 20141:09 pmRNSTransaction in Own Shares
14th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 201412:27 pmRNSTransaction in Own Shares
12th Aug 20142:38 pmRNSTransaction in Own Shares
11th Aug 20144:08 pmRNSTransaction in Own Shares
5th Aug 201411:36 amRNSReplacement Director/PDMR Shareholding
1st Aug 20143:23 pmRNSDirector/PDMR Shareholding
1st Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20143:19 pmRNSDirector/PDMR Shareholding
30th Jul 201411:12 amRNSHalf Yearly Report
4th Jul 20144:34 pmRNSReplacement re Issue of Equity
3rd Jul 20144:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20149:51 amRNSIssue of Equity
28th May 20145:13 pmRNSOffer for Subscription Update
27th May 201410:35 amRNSDirector Declaration
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:52 pmRNSOffer for Subscription - Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.